LOS ANGELES, July 18, 2022
LOS ANGELES, July 18, 2022 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pegasystems Inc. ("Pegasystems" or "the Company") (NASDAQ: PEGA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between May 29, 2020 and May 9, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before July 18, 2022.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at email@example.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Pegasystems engaged in a campaign of corporate espionage and the misappropriation of trade secrets to gain a competitive advantage over rival Appian. The Company's product development and success was driven in part by the theft of trade secrets. The Company's CEO was personally involved in the theft of trade secrets and other corporate espionage activities. The Company was "unable to reasonably estimate damages" in litigation related to Appian. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Pegasystems, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
The Schall Law Firm
Brian Schall, Esq.,
View original content to download multimedia:https://www.prnewswire.com/news-releases/deadline-today-the-schall-law-firm-encourages-investors-in-pegasystems-inc-with-losses-of-500-000-to-contact-the-firm-301588106.html
SOURCE The Schall Law Firm
CAMBRIDGE, Mass., August 2, 2022
CAMBRIDGE, Mass., August 2, 2022 /PRNewswire/ -- Pegasystems Inc. (NASDAQ: PEGA), the low-code platform provider that builds agility into the world's leading organizations, today announced the appointment of Dr. Kikelomo (Dayo) Belizaire as its first chief medical officer. With a strong clinical background and a passion for improving care outcomes, Dr. Belizaire will bring a clinical lens to Pega's strategy for serving its healthcare clients.
With the exact convergence of healthcare payers and providers, these organizations are putting an increased focus on managing overall care and improving outcomes to reduce long-term healthcare costs. Dr. Belizaire will leverage her experience as a practicing physician working closely with both payers and providers to help accelerate and inform the development of Pega's healthcare solutions, ensuring they are clinically relevant and help drive better collaboration between all stakeholders. A Board-certified internal medicine physician with a Master of Public Health, Dr. Belizaire's practitioner background will provide a unique perspective to help Pega clients identify opportunities to leverage Pega's low code, AI-powered decisioning and workflow automation capabilities and understand the value it can provide across their organizations. She brings a wealth of experience in healthcare consulting and hospitalist medicine with a focus on high quality, cost-efficient care delivery models.
Dr. Belizaire most recently served as a medical director in the commercial business unit at Anthem, where she focused on medical management services for company health plans and clinical integrity of programs. At Anthem, she developed close relationships with independent physician practice groups and was selected to oversee a special COVID-19 initiative, leading a multidisciplinary team in the implementation of a new patient outreach program. She also has held a variety of positions at Atrium Health and other health systems in the United States including CaroMont Health, MUSC Health-Florence, McLeod Medical Center, and AnMed Health. In a consulting capacity, Dr. Belizaire has led the development of benchmark utilization tools and analyzed spending trends to help collaborative hospitals become successful in population health.
Dr. Belizaire holds a Bachelor of Arts (BA) in biology from the University of Virginia, and a Master of Public Health (MPH) and Doctor of Medicine (MD) from St. George's University. She is currently an MBA candidate at Wake Forest University and resides in North Carolina with her family.
Pega's healthcare solutions are focused on improving efficiencies and outcomes – from connecting people to the right care and offering personalized and proactive experiences, to improving processes across the whole health journey to optimize a variety of services, including preauthorizations, claims, appeals, and grievances. To learn more about how healthcare organizations can leverage Pega, visit: https://www.pega.com/industries/healthcare.
Quotes & Commentary:
"Digital transformation is crucial in healthcare, and Dr. Belizaire is uniquely qualified to recognize the needs of our clients and ensure Pega solutions meet those needs," said Kelli Bravo, vice president, healthcare and life sciences, Pega. "As chief medical officer, she will provide guidance and leadership to our healthcare clients as they work to Excellerate patient outcomes. Consumerism is driving healthcare to be more like other industries and our clients need tools to adapt, build stronger engagement, and meet their patients where they are. Dr. Belizaire understands the realities of being a healthcare practitioner and will help Pega address our clients' specific pain points and their need to deliver whole-person care."
"I am committed to unlocking the full potential of technology to Excellerate quality and access to care," said Dr. Kikelomo (Dayo) Belizaire, chief medical officer, Pega. "We have the power to transform every step of the healthcare journey. Pega's solutions help navigate the many complexities faced by patients, payers, and providers. With technology, we can ultimately deliver better experiences for all parties involved, and I will be able to help our healthcare clients understand the full scope of what Pega can do for them."
Pega provides a powerful low-code platform that builds agility into the world's leading organizations so they can adapt to change. Clients use our AI-powered decisioning and workflow automation to solve their most pressing business challenges – from personalizing engagement to automating service to streamlining operations. Since 1983, we've built our scalable and flexible architecture so people can meet today's customer demands while continuously transforming for tomorrow. For more information, please visit www.pega.com.
All trademarks are the property of their respective owners.
View original content to download multimedia:https://www.prnewswire.com/news-releases/dr-kikelomo-belizaire-joins-pega-as-the-companys-first-chief-medical-officer-301598012.html
SOURCE Pegasystems Inc.